Where NeuroPace Is Headed Under New CEO Mike Favet

Medtech-Talk-143

EPISODE 143

In this episode, Mike Favet, the new CEO of NeuroPace, shares his personal story into Medtech and reveals his plans for one of Medtech’s pioneers, NeuroPace. What convinced him to become CEO? What changes will he make at NeuroPace?

Podcast Guest

Favet

Mike Favet

CEO

NeuroPace

Michael Favet has 20 years of senior management experience with medical technology companies. He has served on the NeuroPace Board of Directors since 2016 and served as the company’s Chief Commercial Officer prior to assuming the role of Chief Executive Officer in 2019.

Prior to joining NeuroPace, Mr. Favet held various executive-level positions for companies including Advanced Cardiac Therapeutics, Sonitus Medical, Ventus Medical, Boston Scientific and Guidant. Most recently, Mr. Favet was a managing director for KCK’s medtech group, part of a fund for medical technology investments.

Mr. Favet received a BS in Mechanical Engineering from the University of Illinois and an MBA from the University of Minnesota.

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the Medtech Talk Podcast, please complete the application today.

Meet Our Host

Geoff Pardo

Geoff-Pardo

Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.

Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!